3 Magnificent Growth Stocks to Buy in July

The article points to a strong backdrop for growth stocks, noting the S&P 500 is up 14% over the past quarter and the Nasdaq-100 up 26%, largely driven by AI-linked chip strength. It highlights Axon’s 1Q revenue up 34% YoY (SaaS +35%, net revenue retention 125%) with adjusted EPS rising to $1.61 and margins at 19.9%, plus Dutch Bros’ 1Q sales +31% YoY and same-store sales +8.4% and MercadoLibre’s 1Q revenue +49% YoY (GMV +42%, payments +50%). Overall, the news is constructive on these companies’ fundamentals and AI-enabled growth, though it does not provide market-wide policy catalysts.

Analysis

AXON is still more of a recurring-government-workflow compounder than a pure “geopolitical beneficiary.” The market will likely over-rotate on the narrative for a few days, but the durable value driver is software attach and replacement cycles; if the platform is truly mission-critical, budget scrutiny can actually be a moat because switching costs rise when agencies standardize. The main risk is multiple compression if growth stays strong but SaaS deceleration looks even slightly less than hypergrowth, so this is a 1-3 month earnings/guide trade more than a war trade.

BROS looks like a share-taker from SBUX and smaller regional chains, with the second-order effect being menu-price restraint from incumbents protecting traffic. The opportunity is real if unit economics hold while store growth accelerates, but the short-duration risk is commodity, labor, and promotion pressure: any slip in same-store sales can unwind the premium fast. This is a “show me” story over the next 1-2 quarters, not a straight-line comp.

MELI has the best structural setup because underpenetrated payments, credit, and logistics create self-reinforcing operating leverage. The market is still underpricing how much fintech can offset e-commerce cyclicality; the swing factor is whether credit quality and FX stay benign enough for margin expansion to continue into the next earnings print. If profitability reaccelerates, the stock can rerate quickly; if not, it remains vulnerable to Brazil/Mexico macro beta.

Key Decisions for Investors

• AXON: hold/add only on post-rally pullbacks; do not chase headline momentum. Favor a 1-3 month entry after the next earnings reaction if SaaS NRR stays >120% and adjusted margin holds near current levels. Falsifier: any guide that implies software growth normalization faster than expected.
• BROS vs SBUX: initiate a tactical long BROS / short SBUX pair for 1-2 quarters to express trading-down + unit growth while limiting consumer discretionary beta. Best entry is into broader retail weakness; exit if BROS same-store sales decelerate below mid-single digits.
• MELI: buy the Aug. 5 print via call spread or outright long on any pre-earnings weakness. Risk/reward is favorable if management confirms margin expansion and credit costs remain contained; the upside is a rerating on operating leverage, not just top-line growth.
• Sector watch: if SBUX starts cutting prices or materially increasing promo spend, that validates the BROS share-gain thesis and argues for staying long the pair for another 1-2 quarters.
• No aggressive short on AXON yet: wait for evidence that government procurement or SaaS retention is rolling over. Without that, the stock can stay expensive longer than bears expect.